跳至主要内容
临床试验/CTRI/2025/10/095912
CTRI/2025/10/095912尚未招募3 期

Effect of oral furosemide on postpartum blood pressure in women with Hypertensive Disorders in Pregnancy: A Randomised Controlled Trial

Dr Maheshwari GK1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年11月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Prevalence of persistent hypertension 72 hours postpartum or at the time of discharge

研究概览

简要总结

Persistent postpartum hypertension is a significant cause of maternal morbidity including heart failure and stroke.While postpartum hypertension can present following a normotensive pregnancy most postpartum hypertension complications are in women with persistent hypertension following a pregnancy complicated by preeclampsia or Hypertensive disorder in pregnancy.in women with Hypertensive Disorder in pregnancy, blood pressure decreases in first 48hours postpartum and then increases during day 3to 6 postpartum as a result of fluid retention and mobilisation of large volume of sodium into intravascular compartment.This change in fluid dynamics can affect blood pressure and hinder efficient blood pressure control during postpartum.

Hypertensive Disorders in pregnancy include gestational hypertension preeclampsia and preeclampsia superimposed on chronic hypertension with or without severe features

Gestational hypertension is defined as 2BP more than 140/90 mmhg at least 4hours apart with no protein urea and no other laboratory abnormalities

Preeclampsia without severe features has additional requirement of proteinuria

Preeclampsia with severe features is diagnosed after 2 BP readings of more than 160/110 mmhg at least 4 hours apart or any of the abnormal lab parameters

Furosemide being loop diuretic acts on ascending loop of Henley in the kidneys to inhibit sodium and chloride absorption leading to increased urine output.This may be potential to reduce intravascular volume in postpartum period with fluid overload and assist with blood pressure control

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Women diagnosed with Hypertensive Disorder of pregnancy including gestational hypertension preeclampsia with or without severe features Hemodynamically stable patients who delivered a foetus of more than twenty week period of gestation.

排除标准

  • History of allergic reaction to furosemide Hypotension Hypokalaemia Women who received diuretics before randomisation High risk comorbidities for which treatment may be indicated like overt diabetes mellitus chronic kidney disease cardiac disorders of pregnancy.

结局指标

主要结局

Prevalence of persistent hypertension 72 hours postpartum or at the time of discharge

时间窗: 72hours postpartum

次要结局

  • Percentage of postpartum BP in severe range(Need for any additional anti Hypertensive medication postpartum)

研究者

发起方
Dr Maheshwari GK
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Maheshwari GK

Jawaharlal Nehru Medical College , KLE Belagavi

研究点 (1)

Loading locations...

相似试验